Society for Obstetric Anesthesia and Perinatology Consensus Statement: Monitoring Recommendations for Prevention and Detection of Respiratory Depression Associated With Administration of Neuraxial Morphine for Cesarean Delivery Analgesia

• Published in: Anesthesia and analgesia Vol. 129; no. 2; pp. 458 - 474
• Main Authors: Bauchat, Jeanette R, Weiniger, Carolyn F, Sultan, Pervez, Habib, Ashraf S, Ando, Kazuo, Kowalczyk, John J, Kato, Rie, George, Ronald B, Palmer, Craig M, Carvalho, Brendan
• Format: Journal Article
• Language: English
• Published: United States International Anesthesia Research Society 01.08.2019
• Subjects: Analgesia, Obstetrical - adverse effects; Analgesics, Opioid - administration & dosage; Analgesics, Opioid - adverse effects; Cesarean Section - adverse effects; Consensus; Drug Administration Schedule; Female; Humans; Lung - drug effects; Lung - physiopathology; Morphine - administration & dosage; Morphine - adverse effects; Pain, Postoperative - etiology; Pain, Postoperative - prevention & control; Pregnancy; Respiration - drug effects; Respiratory Insufficiency - chemically induced; Respiratory Insufficiency - diagnosis; Respiratory Insufficiency - physiopathology; Respiratory Insufficiency - prevention & control; Risk Assessment; Risk Factors; Treatment Outcome

The majority of women undergoing cesarean delivery in the United States receive neuraxial morphine, the most effective form of postoperative analgesia for this surgery. Current American Society of Anesthesiologists (ASA) and American Society of Regional Anesthesia and Pain Medicine (ASRA) recommend...